Minaris Introduces Innovative AgentSCREEN System to Enhance Viral Safety Testing in Cell Therapy Minaris has unveiled its AgentSCREEN system, utilizing NGS technology to streamline viral safety evaluation for biopharma products, ensuring rapid results.

Minaris Introduces Innovative AgentSCREEN System to Enhance Viral Safety Testing in Cell Therapy #USA #Philadelphia #Minaris #AgentSCREEN #Adventitious_Virus

Minaris Enhances Viral Clearance Laboratory to Boost Biomanufacturing in Philadelphia Minaris has announced an upgrade to its Viral Clearance laboratory in Philadelphia. This investment enhances capacity and throughput, improving efficiency for clients.

Minaris Enhances Viral Clearance Laboratory to Boost Biomanufacturing in Philadelphia #United_States #Philadelphia #Minaris #Viral_Clearance

Minaris and Genetix Biotherapeutics Enhance Production of LYFGENIA™ for Sickle Cell Treatment Minaris and Genetix Biotherapeutics announced an expanded manufacturing partnership to significantly enhance the production of LYFGENIA™, a vital gene therapy for sickle cell disease, addressing patient needs effectively.

Minaris and Genetix Biotherapeutics Enhance Production of LYFGENIA™ for Sickle Cell Treatment #USA #Philadelphia #Minaris #LYFGENIA #Genetix

Minaris and Cell and Gene Therapy Catapult Team Up to Innovate Delivery Systems for Cell and Gene Therapies Minaris and Cell and Gene Therapy Catapult have announced a collaboration aimed at enhancing delivery methods for cell and gene therapies, fostering improved manufacturing and innovation.

Minaris and Cell and Gene Therapy Catapult Team Up to Innovate Delivery Systems for Cell and Gene Therapies #USA #Philadelphia #gene_therapy #Minaris #CGT_Catapult

Minaris Collaborates with Cell and Gene Therapy Catapult to Enhance Gene Therapy Delivery Technologies Minaris partners with the Cell and Gene Therapy Catapult to advance gene therapy delivery methods, improving manufacturing quality and reducing costs.

Minaris Collaborates with Cell and Gene Therapy Catapult to Enhance Gene Therapy Delivery Technologies #USA #London #gene_therapy #Minaris #CGT_Catapult

Minaris Advanced Therapies Launches New GMP Facility to Foster Global Cell and Gene Therapy Innovation Discover how Minaris Advanced Therapies' new GMP facility in Munich bolsters global cell and gene therapy manufacturing and innovation.

Minaris Advanced Therapies Launches New GMP Facility to Foster Global Cell and Gene Therapy Innovation #Germany #Munich #gene_therapy #Minaris #GMP_Facility

Minaris Advanced Therapies Appoints Dr. Orla Cloak as CEO for Growth Strategy Minaris Advanced Therapies announces the appointment of Dr. Orla Cloak as CEO to spearhead innovation and operational excellence in therapy commercialization.

Minaris Advanced Therapies Appoints Dr. Orla Cloak as CEO for Growth Strategy #USA #Philadelphia #CEO #Minaris #Orla_Cloak

Minaris Advanced Therapies Announces New CEO Dr. Orla Cloak to Lead the Company Minaris Advanced Therapies proudly welcomes Dr. Orla Cloak as the new CEO. With over 20 years in pharma and biotech, she aims to drive innovation and growth.

Minaris Advanced Therapies Announces New CEO Dr. Orla Cloak to Lead the Company #None #Philadelphia #CEO_Appointment #Minaris #Orla_Cloak

湘南アイパークに新設される細胞培養加工施設の全貌とは？ 湘南アイパークに新たに設立される細胞培養加工施設が2025年11月に稼働予定。スタートアップに新たな製造の選択肢を提供します。

湘南アイパークに新設される細胞培養加工施設の全貌とは？ #神奈川県 #藤沢市 #Minaris #湘南アイパーク #細胞医薬品

湘南アイパークに新たに設立される細胞培養加工施設が2025年11月に稼働予定。スタートアップに新たな製造の選択肢を提供します。

Minaris Advanced Therapies: Global Leader in Cell Therapy Development, Manufacturing, and Testing Minaris Advanced Therapies emerges as a key player in the cell therapy sector, uniting innovative capabilities for development and manufacturing on a global scale.

Minaris Advanced Therapies: Global Leader in Cell Therapy Development, Manufacturing, and Testing #USA #Philadelphia #Wuxi #Cell_Therapy #Minaris

Minaris Advanced Therapies Emerges as a Global Leader in Cell Therapy Development Minaris Advanced Therapies has been established as a prominent player in cell therapy, combining expertise and facilities across the globe to expedite patient treatment.

Minaris Advanced Therapies Emerges as a Global Leader in Cell Therapy Development #USA #Philadelphia #Cell_Therapy #Altaris #Minaris

再生医療の新たな未来へ：アルフレッサHDとMinarisが協業覚書を締結 アルフレッサホールディングスとMinarisが再生医療市場での協業覚書を締結。お互いの強みを活かし、医療ニーズに応えます。

再生医療の新たな未来へ：アルフレッサHDとMinarisが協業覚書を締結 #再生医療 #Minaris #アルフレッサHD

アルフレッサホールディングスとMinarisが再生医療市場での協業覚書を締結。お互いの強みを活かし、医療ニーズに応えます。

再生医療を支える新たな提携！アルフレッサHDとMinarisの協業 アルフレッサホールディングスとMinarisの新たな協業が発表されました。再生医療領域での共同プロモーションで医療ニーズに応えます。

再生医療を支える新たな提携！アルフレッサHDとMinarisの協業 #再生医療 #アルフレッサHD #Minaris

アルフレッサホールディングスとMinarisの新たな協業が発表されました。再生医療領域での共同プロモーションで医療ニーズに応えます。

再生医療の未来を切り開くアルフレッサHDとMinarisの協業 アルフレッサホールディングスとMinarisが再生医療の商用生産に向けて協力。両社の強みを生かした新たな取り組みが期待される。

再生医療の未来を切り開くアルフレッサHDとMinarisの協業 #東京都 #千代田区 #再生医療 #Minaris #アルフレッサHD

アルフレッサホールディングスとMinarisが再生医療の商用生産に向けて協力。両社の強みを生かした新たな取り組みが期待される。

再生医療の未来を切り開く！Minaris社との新たな協業について Minaris Regenerative Medicineとの提携により、再生医療分野におけるブランドが一層強化されます。革新医薬品の早期提供へ向けた取り組みを追う。

再生医療の未来を切り開く！Minaris社との新たな協業について #再生医療 #医薬品 #Minaris

Minaris Regenerative Medicineとの提携により、再生医療分野におけるブランドが一層強化されます。革新医薬品の早期提供へ向けた取り組みを追う。